Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity.

about

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity.

Item

http://www.wikidata.org/entity/Q54980314

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Rapidly progressive dyspnea in ...... ith imatinib cardiac toxicity.

@en

Rapidly progressive dyspnea in gastrointestinal stromal tumor

@nl

type

Item

label

Rapidly progressive dyspnea in ...... ith imatinib cardiac toxicity.

@en

Rapidly progressive dyspnea in gastrointestinal stromal tumor

@nl

prefLabel

Rapidly progressive dyspnea in ...... ith imatinib cardiac toxicity.

@en

Rapidly progressive dyspnea in gastrointestinal stromal tumor

@nl

P1476

Rapidly progressive dyspnea in ...... ith imatinib cardiac toxicity.

@en

P2093

Adnan Asif Parvez Ghias

http://www.w3.org/2001/XMLSchema#string

Shahzeem Bhayani

http://www.w3.org/2001/XMLSchema#string

Sudershan K Garg

http://www.w3.org/2001/XMLSchema#string

P2860

An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Congestive heart failure is a rare event in patients receiving imatinib therapy.

A gist of gastrointestinal stromal tumors: A review.

Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.

Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management

Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.

Imatinib-induced decompensated heart failure in an elderly patient with chronic myeloid leukemia: case report and literature review.

P304

87-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1080/20009666.2018.1454787

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David J Gemmel

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686796

http://www.w3.org/2001/XMLSchema#string

P932

5906758

http://www.w3.org/2001/XMLSchema#string